The Efficacy and Safety of PD-1 Inhibitors Combined with Nab-Paclitaxel Plus Gemcitabine versus Nab-Paclitaxel Plus Gemcitabine in the First-Line Treatment of Advanced Pancreatic Cancer: A Retrospective Monocentric Study

PURPOSE: The purpose of this study was to evaluate the efficacy and safety of PD-1 inhibitor combined with nab-paclitaxel plus gemcitabine (AG) chemotherapy versus AG chemotherapy in the first-line treatment of advanced pancreatic cancer. PATIENTS AND METHODS: This study included the application of...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Feng, Wang, Yuyang, Yang, Fangfang, Zhang, Yuming, Jiang, Man, Zhang, Xiaochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841313/
https://www.ncbi.nlm.nih.gov/pubmed/35173487
http://dx.doi.org/10.2147/CMAR.S349442

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8841313/
https://www.ncbi.nlm.nih.gov/pubmed/35173487
http://dx.doi.org/10.2147/CMAR.S349442

Ejemplares similares